Status:
COMPLETED
Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients
Lead Sponsor:
ResMed
Collaborating Sponsors:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Nocturnal Hypoventilation
Neuromuscular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients with newly diagnosed nocturnal hypoventilation who have ne...
Detailed Description
The aim of the study is to compare the effect of two types of noninvasive ventilator (a small machine that assists breathing) in patients newly diagnosed with nocturnal hypoventilation who are inexper...
Eligibility Criteria
Inclusion
- new clinical diagnosis of nocturnal hypoventilation
- requirement for long-term domiciliary non-invasive ventilation
- no previous experience with domiciliary non-invasive ventilation
Exclusion
- uncontrolled cardiac failure
- acute exacerbation of respiratory failure
- daytime resting PaO2 \< 7.5kPa
- moderate or severe bulbar weakness
- inability to understand rationale and/or consent form for study
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00901485
Start Date
April 1 2009
End Date
March 1 2011
Last Update
June 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital
London, United Kingdom, SW3 6NP